Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Stem Cell Technique Makes Sperm in a Dish

February 26, 2016 By Cell Press

Scientists in China have finally succeeded in creating functioning sperm from mice in the laboratory. To accomplish this feat, the researchers coaxed mouse embryonic stem cells to turn into functional sperm-like cells, which were then injected into egg cells to produce fertile mouse offspring. The work, reported February 25 in Cell Stem Cell, provides a platform for generating sperm cells that could one day be used to treat male infertility in humans.

This graphical abstract shows how Zhou et al. generated haploid male gametes from mouse embryonic stem cells that can produce viable and fertile offspring, demonstrating functional reproduction of meiosis in vitro. (Credit: Zhou, Wang, and Yuan et al./Cell Stem Cell 2016)

“Reproducing germ cell development in vitro has remained a central goal in both reproductive biology and reproductive medicine,” says co-senior study author Jiahao Sha of Nanjing Medical University. “We established a robust, stepwise approach that recapitulates the formation of functional sperm-like cells in a dish. Our method fully complies with the gold standards recently proposed by a consensus panel of reproductive biologists, so we think that it holds tremendous promise for treating male infertility.”

Infertility affects up to 15% of couples, and about one-third of cases can be traced to the man. One major cause of male infertility is the failure of precursor germ cells in the testes to undergo a type of cell division called meiosis to form functional sperm cells. Several studies have reported the successful generation of germ cells from stem cells, but they did not fully evaluate the functionality of the germ cells or provide proof for all key hallmarks of meiosis.

Recently, a panel of reproductive biologists proposed gold standard criteria to prove that the major events of meiosis have taken place in engineered germ cells. For example, researchers must show evidence of the correct nuclear DNA content at specific meiotic stages, normal chromosome number and organization, and the capacity of germ cells to produce viable offspring. Until now, the recapitulation of all of the essential steps of meiosis has remained a major obstacle to the production of functional sperm and egg cells in a dish.

To overcome this hurdle, Sha teamed up with co-senior study authors Qi Zhou and Xiao-Yang Zhao of the Institute of Zoology at the Chinese Academy of Sciences to develop a stem cell-based method that fully recapitulates meiosis and produces functional sperm-like cells. The first step was to expose mouse embryonic stem cells (ESCs) to a chemical cocktail, which coaxed the ESCs to turn into primordial germ cells. Next, the researchers mimicked the natural tissue environment of these precursor germ cells by exposing them to testicular cells as well as sex hormones such as testosterone.

Under these biologically relevant conditions, the ESC-derived primordial germ cells underwent complete meiosis, resulting in sperm-like cells with correct nuclear DNA and chromosomal content. To provide final gold-standard proof of meiosis, the researchers injected these sperm-like cells into mouse egg cells and transferred the embryos into female mice. Remarkably, these embryos developed normally and gave rise to healthy, fertile offspring, which gave birth to the next generation.

In future studies, the researchers plan to use their platform to examine the molecular mechanisms controlling meiosis. They will also test their approach in other animals such as primates in anticipation of human studies. However, before this technique is translated to the clinic, possible risks must be ruled out and ethical concerns regarding the use of embryonic cells should be considered.

“If proven to be safe and effective in humans, our platform could potentially generate fully functional sperm for artificial insemination or in vitro fertilization techniques,” Sha says. “Because currently available treatments do not work for many couples, we hope that our approach could substantially improve success rates for male infertility.”

Find more information on the study here.

Related Articles Read More >

UltiMaker and Bioactivx advance on-demand 3D-printed wound care
A photo of Conexeu Sciences co-founder and Chief Scientific Officer Dr. Claudia Chavez-Munoz.
This tissue engineering scientist is bioprinting next-gen absorbable implants
July 2026 issue: Robotic stroke telesurgery’s time is now
Nanoscopic imaging showing human keratinocyte-matrix interaction.
These smart materials are key to advancing regenerative medicine
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe